Corrigendum to "3rd ESO-ESMO international consensus guidelines for advanced breast cancer (ABC 3)" [Breast 31 (February 2017) 244-259]

F Cardoso¹, A Costa², E Senkus³, M Aapro⁴, F André⁵, C H Barrios⁶, J Bergh⁷, G Bhattacharyya⁸, L Biganzoli⁹, M J Cardoso¹⁰, L Carey¹¹, D Corneliussen-James¹², G Curigliano¹³, V Dieras¹⁴, N El Saghir¹⁵, A Eniu¹⁶, L Fallowfield¹⁷, D Fenech¹⁸, P Francis¹⁹, K Gelmon²⁰, A Gennari²¹, N Harbeck²², C Hudis²³, B Kaufman²⁴, I Krop²⁵, M Mayer²⁶, H Meijer²⁷, S Mertz²⁸, S Ohno²⁹, O Pagani³⁰, E Papadopoulos³¹, F Peccatori², F Penault-Llorca³², M J Piccart³³, J Y Pierga³⁴, H Rugo³⁵, L Shockney³⁶, G Sledge³⁷, S Swain³⁸, C Thomssen³⁹, A Tutt⁴⁰, D Vorobiof⁴¹, B Xu⁴², L Norton⁴³, E Winer²⁵

Affiliations

¹ European School of Oncology & Breast Unit, Champalimaud Clinical Center, Lisbon, Portugal. Electronic address: fatimacardoso@fundacaochampalimaud.pt.
² European School of Oncology, Milan, Italy; European School of Oncology, Bellinzona, Switzerland.
³ Department of Oncology and Radiotherapy, Medical University of Gdansk, Gdansk, Poland.
⁴ Breast Center, Genolier Cancer Center, Genolier, Switzerland.
⁵ Department of Medical Oncology, Gustave Roussy Institute, Villejuif, France.
⁶ Department of Medicine, PUCRS School of Medicine, Porto Alegre, Brazil.
⁷ Department of Oncology/Radiumhemmet, Karolinska Institutet & Cancer Center Karolinska and Karolinska University Hospital, Stockholm, Sweden.
⁸ Department of Medical Oncology, Fortis Hospital, Kolkata, India.
⁹ Medical Oncology Department, Hospital of Prato, Prato, Italy.
¹⁰ Breast Unit, Champalimaud Clinical Center, Lisbon, Portugal.
¹¹ Department of Hematology and Oncology, UNC Lineberger Comprehensive Cancer Center, USA.
¹² METAvivor Research and Support, Annapolis, USA.
¹³ Division of Experimental Therapeutics, European Institute of Oncology, Milan, Italy.
¹⁴ Department of Medical Oncology, Institut Curie, Paris, France.
¹⁵ NK Basile Cancer Institute Breast Center of Excellence, American University of Beirut, Beirut, Lebanon.
¹⁶ Department of Breast Tumors, Cancer Institute 'I. Chiricuta', Cluj-Napoca, Romania.
¹⁷ Brighton & Sussex Medical School, University of Sussex, Falmer, UK.
¹⁸ Breast Care Support Group, Europa Donna Malta, Mtarfa, Malta.
¹⁹ Division of Cancer Medicine, Peter MacCallum Cancer Centre, Melbourne, Australia.
²⁰ BC Cancer Agency, Vancouver Cancer Centre, Vancouver, Canada.
²¹ Department of Medical Oncology, Galliera Hospital, Genoa, Italy.
²² Brustzentrum der Universitat München, Munich, Germany.
²³ Breast Medicine Service, Memorial Sloan-Kettering Cancer Centre, New York, USA.
²⁴ Sheba Medical Center, Tel Hashomer, Israel.
²⁵ Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, USA.
²⁶ Advanced BC.org, New York, USA.
²⁷ Department of Radiation Oncology, Radvoud University Medical Center, Nijmegen, The Netherlands.
²⁸ Metastatic Breast Cancer Network US, Inversness, USA.
²⁹ Breast Oncology Centre, Cancer Institute Hospital, Tokyo, Japan.
³⁰ Oncology Institute of Southern Switzerland and Breast Unit of Southern Switzerland, Bellinzona, Switzerland.
³¹ Europa Donna, Nicosia, Cyprus.
³² Jean Perrin Centre, Comprehensive Cancer Centre, Clermont Ferrand, France.
³³ Department of Medicine, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium.
³⁴ Department of Medical Oncology, Institut Curie-Université Paris Descartes, Paris, France.
³⁵ Department of Medicine, Breast Oncology Program, UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco, USA.
³⁶ Department of Surgery and Oncology, Johns Hopkins Breast Center, Baltimore, USA.
³⁷ Indiana University Medical CTR, Indianapolis, USA.
³⁸ Lombardi Comprehensive Cancer Center, Georgetown University, Washington, USA.
³⁹ Department of Gynaecology, Martin-Luther-University Halle-Wittenberg, Halle an der Saale, DE, Germany.
⁴⁰ Breakthrough Breast Cancer Research Unit, King's College London and Guy's and St Thomas's NHS Foundation Trust, London, UK.
⁴¹ Sandton Oncology Centre, Johannesburg, South Africa.
⁴² Department of Medical Oncology, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, China.
⁴³ Breast Cancer Program, Memorial Sloan-Kettering Cancer Centre, New York, USA.

PMID: 28109648
DOI: 10.1016/j.breast.2017.01.001

Published Erratum

Corrigendum to "3rd ESO-ESMO international consensus guidelines for advanced breast cancer (ABC 3)" [Breast 31 (February 2017) 244-259]

F Cardoso et al. Breast. 2017 Apr.

. 2017 Apr:32:269-270.

doi: 10.1016/j.breast.2017.01.001. Epub 2017 Jan 18.

Authors

Affiliations

¹ European School of Oncology & Breast Unit, Champalimaud Clinical Center, Lisbon, Portugal. Electronic address: fatimacardoso@fundacaochampalimaud.pt.
² European School of Oncology, Milan, Italy; European School of Oncology, Bellinzona, Switzerland.
³ Department of Oncology and Radiotherapy, Medical University of Gdansk, Gdansk, Poland.
⁴ Breast Center, Genolier Cancer Center, Genolier, Switzerland.
⁵ Department of Medical Oncology, Gustave Roussy Institute, Villejuif, France.
⁶ Department of Medicine, PUCRS School of Medicine, Porto Alegre, Brazil.
⁷ Department of Oncology/Radiumhemmet, Karolinska Institutet & Cancer Center Karolinska and Karolinska University Hospital, Stockholm, Sweden.
⁸ Department of Medical Oncology, Fortis Hospital, Kolkata, India.
⁹ Medical Oncology Department, Hospital of Prato, Prato, Italy.
¹⁰ Breast Unit, Champalimaud Clinical Center, Lisbon, Portugal.
¹¹ Department of Hematology and Oncology, UNC Lineberger Comprehensive Cancer Center, USA.
¹² METAvivor Research and Support, Annapolis, USA.
¹³ Division of Experimental Therapeutics, European Institute of Oncology, Milan, Italy.
¹⁴ Department of Medical Oncology, Institut Curie, Paris, France.
¹⁵ NK Basile Cancer Institute Breast Center of Excellence, American University of Beirut, Beirut, Lebanon.
¹⁶ Department of Breast Tumors, Cancer Institute 'I. Chiricuta', Cluj-Napoca, Romania.
¹⁷ Brighton & Sussex Medical School, University of Sussex, Falmer, UK.
¹⁸ Breast Care Support Group, Europa Donna Malta, Mtarfa, Malta.
¹⁹ Division of Cancer Medicine, Peter MacCallum Cancer Centre, Melbourne, Australia.
²⁰ BC Cancer Agency, Vancouver Cancer Centre, Vancouver, Canada.
²¹ Department of Medical Oncology, Galliera Hospital, Genoa, Italy.
²² Brustzentrum der Universitat München, Munich, Germany.
²³ Breast Medicine Service, Memorial Sloan-Kettering Cancer Centre, New York, USA.
²⁴ Sheba Medical Center, Tel Hashomer, Israel.
²⁵ Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, USA.
²⁶ Advanced BC.org, New York, USA.
²⁷ Department of Radiation Oncology, Radvoud University Medical Center, Nijmegen, The Netherlands.
²⁸ Metastatic Breast Cancer Network US, Inversness, USA.
²⁹ Breast Oncology Centre, Cancer Institute Hospital, Tokyo, Japan.
³⁰ Oncology Institute of Southern Switzerland and Breast Unit of Southern Switzerland, Bellinzona, Switzerland.
³¹ Europa Donna, Nicosia, Cyprus.
³² Jean Perrin Centre, Comprehensive Cancer Centre, Clermont Ferrand, France.
³³ Department of Medicine, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium.
³⁴ Department of Medical Oncology, Institut Curie-Université Paris Descartes, Paris, France.
³⁵ Department of Medicine, Breast Oncology Program, UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco, USA.
³⁶ Department of Surgery and Oncology, Johns Hopkins Breast Center, Baltimore, USA.
³⁷ Indiana University Medical CTR, Indianapolis, USA.
³⁸ Lombardi Comprehensive Cancer Center, Georgetown University, Washington, USA.
³⁹ Department of Gynaecology, Martin-Luther-University Halle-Wittenberg, Halle an der Saale, DE, Germany.
⁴⁰ Breakthrough Breast Cancer Research Unit, King's College London and Guy's and St Thomas's NHS Foundation Trust, London, UK.
⁴¹ Sandton Oncology Centre, Johannesburg, South Africa.
⁴² Department of Medical Oncology, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, China.
⁴³ Breast Cancer Program, Memorial Sloan-Kettering Cancer Centre, New York, USA.

PMID: 28109648
DOI: 10.1016/j.breast.2017.01.001

No abstract available

PubMed Disclaimer

Erratum for

3rd ESO-ESMO international consensus guidelines for Advanced Breast Cancer (ABC 3).
Cardoso F, Costa A, Senkus E, Aapro M, André F, Barrios CH, Bergh J, Bhattacharyya G, Biganzoli L, Cardoso MJ, Carey L, Corneliussen-James D, Curigliano G, Dieras V, El Saghir N, Eniu A, Fallowfield L, Fenech D, Francis P, Gelmon K, Gennari A, Harbeck N, Hudis C, Kaufman B, Krop I, Mayer M, Meijer H, Mertz S, Ohno S, Pagani O, Papadopoulos E, Peccatori F, Penault-Llorca F, Piccart MJ, Pierga JY, Rugo H, Shockney L, Sledge G, Swain S, Thomssen C, Tutt A, Vorobiof D, Xu B, Norton L, Winer E. Cardoso F, et al. Breast. 2017 Feb;31:244-259. doi: 10.1016/j.breast.2016.10.001. Epub 2016 Dec 5. Breast. 2017. PMID: 27927580 No abstract available.

Publication types

Actions

Grants and funding

P30 CA016086/CA/NCI NIH HHS/United States

LinkOut - more resources

Full Text Sources
- ClinicalKey
- Elsevier Science
Other Literature Sources
- scite Smart Citations

Save citation to file

Email citation

Add to Collections

Add to My Bibliography

Your saved search

Create a file for external citation management software

Your RSS Feed

Corrigendum to "3rd ESO-ESMO international consensus guidelines for advanced breast cancer (ABC 3)" [Breast 31 (February 2017) 244-259]

Affiliations

Corrigendum to "3rd ESO-ESMO international consensus guidelines for advanced breast cancer (ABC 3)" [Breast 31 (February 2017) 244-259]

Authors

Affiliations

Erratum for

Publication types

Grants and funding

LinkOut - more resources

Full Text Sources

Other Literature Sources